SEC Form 4 · accession 0001140361-18-044723
Aquestive Therapeutics, Inc. · AQST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T. Maxwell
Officer — SVP-Chief Financial Officer
Period of report
Dec 6, 2018
Accepted (ET)
Dec 7, 2018 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001398733
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 6, 2018 | P | 5,000 | $8.87 | A | 153,614 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.